RTL
RLAY icon

Red Tortoise LLC’s Relay Therapeutics RLAY Stock Holding History

Red Tortoise LLC’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.95K Hold
698
– – ﹤0.01% 343
2025
Q4 		$5.91K Hold
698
– – ﹤0.01% 360
2025
Q3 		$3.64K Hold
698
– – ﹤0.01% 439
2025
Q2 		$2.42K Buy
+698
New +$2.08K ﹤0.01% 491
2023
Q3 		– Sell
-126
Closed -$1.58K – 578
2023
Q2 		$1.58K Buy
+126
New +$1.57K ﹤0.01% 498

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Red Tortoise LLC's RLAY Position: Q1 2026 in Review

Red Tortoise LLC held its Relay Therapeutics (RLAY) position steady in Q1 2026 at 698 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #343.

Red Tortoise LLC first reported a position in RLAY in Q2 2023 and has held it in 5 quarters since. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Red Tortoise LLC held 698 shares of Relay Therapeutics worth $6.95K as of Q1 2026.
  • Red Tortoise LLC left its Relay Therapeutics share count unchanged in Q1 2026.
  • Relay Therapeutics made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #343 holding.
  • Red Tortoise LLC first reported a position in Relay Therapeutics in Q2 2023 and has held it in 5 quarters since.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.